SM_272b: Head and Neck Cancer Flashcards

1
Q

___ are more likely to get head and neck cancer

A

Males are more likely to get head and neck cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Describe risk factors for head and neck cancer

A

Risk factors for head and neck cancer

  • Age: > 50
  • Tobacco
  • Alcohol
  • Viral: EBV (nasopharyngeal), HPV (oropharynx, oral)
  • Plummer-Vinson syndrome (iron deficiency)
  • Hereditary (rare): family history increases risk, rare genetic syndromes such as Fanconi’s anemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe groups of head and neck cancer

A

Head and neck cancer

  • HPV-related cancers: caused by high-risk HPV (16) and driven by viral oncogenes, restricted to oropharynx (base of tongue and tonsil), distinct molecular markers, good prognosis, young and in good general health
  • Environment-related cancers: caused by environmental mutagens (smoking, alcohol, woodwork), throughout oral mucosa / field cancerization, distinct molecular markers, poor prognosis and comorbidity, second cancers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

HPV is a ___ virus

A

HPV is a dsDNA virus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe HPV

A

HPV

  • dsDNA
  • Infections epithelial cells in skin and oral / genital / anal mucosa in key areas
  • Aysmptomatic
  • > 100 different genotypes
  • Benign: 6 and 11
  • High risk: 16 and 18
  • Exposure to marijuana
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

____ is most common in HPV+ oropharyngeal cancer

A

HPV16 is most common in HPV+ oropharyngeal cancer

  • HPV 16 and 18 are high risk
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe epithelial cell transfection by HPV

A

Epithelial cell transfection by HPV

  • Immune escape -> persistent HPV infection
  • Viral oncoproteins E6 and E7 mediate malignant transformation in infected cell
  • HPV depends on host cell replication proteins for viral DNA synthesis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

HPV ___ and ___ associate with and reprogram cellular enzymes

A

HPV E6 and E7 oncoproteins associate with and reprogram cellular enzymes

  • Target associated cellular tumor suppressors for degradation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

HPV16 E6 ___

A

HPV16 E6 retargets the cellular ubiquitin ligase E6AP to the p53 tumor suppressor protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

HPV16 E7 ___

A

HPV16 E7 retargets the cellular cullin 2 ubiquitin ligase complex to the retinoblastoma tumor suppressor protein pRB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe oncogenic effect of HPV E6 and E7 proteins on host cells

A

Oncogenic effect of HPV E6 and E7 proteins on host cells

  • p53, Rb degradation / loss: cell is lead to path of uncontrolled proliferation -> malignant transformation
  • Rb degradation -> activation of E2F transcription factor -> drives cell cycle from G1 to S phase -> expression of S phase genes -> hyperproliferation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe function of p16

A

p16

  1. p16 inhibits CDK
  2. de-pRb
  3. transcriptional repression
  4. Cell cycle control

inhibited by oncogenic changes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe the role of p16 in the Rb pathway

A

Role of p16 in the Rb pathway

  • Rb proteins suppress transactivation factor of E2F -> inhibit transcription
  • Phosphorylation of Rb proteins by CDK4/6 -> disrupts Rb + E2F interaction -> unbound / activated E2F -> S phase gene transcription -> G1 to S phase -> cell proliferation
  • Degradation of Rb by E7 -> overexpression of p16 (feedback loop) -> surrogate marker for HPV+ oropharyngeal cancer
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe presentation of oropharyngeal cancer

A

Oropharyngeal cancer presentation

  • Lesions in mouth: persistent mass or ulcer, usually in oral cavity
  • Persistent hoarseness
  • Persistent sore throat
  • Difficulties in moving tongue or jaws: chewing, swallowing, or speaking
  • Palpable mass in neck
  • Ear pain: otalgia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe diagnostic evaluation of head and neck cancer

A

Diagnostic evaluation of head and neck cancer

  • ENT
  • Indirect largyngoscopy: using mirros to visualize the larynx
  • Transnasal flexible fiberoptic laryngoscopy: direct visualization of oral / nasal cavity, nasopharynx, oropharynx, larynx
  • FNA biopsy
  • Panendoscopy (under anesthesia: laryngoscopy / esophagoscopy / bronchoscopy, biopsies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Cancer of head and neck appears as ___ on pathology

A

Cancer of head and neck appears as squamous cell carcinoma ± keratinization on pathology

  • Squamous cell carcinoma of larynx: poorly differentiated, hyperchromatic nuclei, polymorphism, high nucleus to cytoplasm ratio
  • Squamous cell carcinoma with basaloid features: more aggressive, can be seen in HPV tumors, basophilic oval tumors, high nucleus to cytoplasm ratio
  • Keratinization: keratin pearls
17
Q

HPV tumors of head and neck stain for ___

A

HPV tumors of head and neck stain for p16

18
Q

Describe diagnostic evaluation of head and neck cancer

A

Diagnostic evaluation of head and neck cancer

  • CT neck with contrast: assess extent of primary tumor, assess lymphadenopathy
  • PET/CT: staging
  • MRI: only if needed to assess for resectability
19
Q

Staging of head and neck cancer involves ___

A

Staging of head and neck cancer involves TNM staging

  • T staging is individualized to each site of origin
20
Q

Describe TNM staging of head and neck cancer

A

TNM staging of head and neck cancer

  • T
    • T1, T2: small tumors, localized
    • T3: large tumors, invading adjacent structures
    • T4: locally advanced tumor, invading surrounding structures
  • N
    • N1: ispilateral single lymph node ≤ 3 cm
    • N2a: ipsilateral single lymph node 3-6 cm
    • N2b: multiple ipsilateral lymph nodes all < 6 cm
    • N2c: bilateral lymph nodes, all < 6 cm
    • N3: lymph node > 6 cm
21
Q

Describe treatment of head and neck cancer

A

Head and neck cancer treatment

  • Early stage (I, II: localized T1-2N0M0): radiation or surgery
  • Locally advanced (III, IVA, IVBL T1-4N1-3M0): multi-modality therapy
  • Metastatic recurrent: palliative chemo, immune therapy, targeted therapy
22
Q

Describe challenges of surgery for head and neck cancer

A

Challenges of surgery for head and neck cancer

  • Disfigurement and dysfunction
  • Voice loss, inability to eat / speak / swallow
  • Tracheostomy
  • Psychological and physical stresses: reduced quality of life
23
Q

Described advanced stage laryngeal carcinoma

A

Advanced stage laryngeal carcinoma

  • Most patients with induction did not require laryngectomy
  • Trend towards benefit in reduction of metastatic disease in chemo arms
  • Adding chemotherapy improved survival
24
Q

Adjunctive chemotherapy ___ survival in head and neck cancer

A

Adjunctive chemotherapy improves survival in head and neck cancer

25
Q

Chemoradiation ___ outcomes in head and neck cancer

A

Chemoradiation improves outcomes in head and neck cancer

26
Q

Describe role of HPV in head and neck cancer

A

HPV

  • Strong association with oropharynx
  • Non-smokers, non-drinkers
  • Younger age, male predominance
  • HPV 16
  • Better prognosis compared with non-HPV associated head and neck cancer
  • Detection: accuracy better with ISH or PCR, practicality better with p16 IHC
27
Q

Describe field cancerization

A

Field cancerization

  • Areas surrounding cancer are genetically abnormal clones
  • Multiple areas of precancer and cancer exist
  • Occurs in response to carcinogen exposure
  • Explains high rate of recurrence following resection of cancer